HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allyson J Campbell Selected Research

4- (6- cyclohexylmethoxy- 9H- purin- 2- ylamino)- N,N- diethylbenzamide

9/2005Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allyson J Campbell Research Topics

Disease

1Carcinoma (Carcinomatosis)
09/2005
1Neoplasms (Cancer)
09/2005
1Ovarian Neoplasms (Ovarian Cancer)
09/2005

Drug/Important Bio-Agent (IBA)

16- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA
09/2005
14- (6- cyclohexylmethoxy- 9H- purin- 2- ylamino)- N,N- diethylbenzamideIBA
09/2005
1SurvivinIBA
09/2005
1Paclitaxel (Taxol)FDA LinkGeneric
09/2005
1Caspase 3 (Caspase-3)IBA
09/2005
1Caspase 9IBA
09/2005

Therapy/Procedure

1Therapeutics
09/2005